Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities:
Net loss	$ (3,778,424)	$ (4,662,924)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	516,228	149,919
Stock based compensation	1,141,023	1,380,642
Proceeds from legal settlement	(540,059)
Common stock issued for services	17,491
Common stock issued for services – related party	39,100
Change in fair value of derivative liability		(4,128)
Loss on extinguishment of convertible note payable		15,076
Amortization of debt discount		22,084
Changes in operating assets and liabilities:
Accounts receivable	3,475	6,525
Prepaid expenses and other current assets	(131,520)	(7,350)
Accounts payable and accrued expenses	193,260	342,370
Payable to related parties	14,356	(24,198)
Deferred revenue	42,158	5,073
Net cash flows used in operating activities	(2,482,912)	(2,776,911)
Cash Flows from Investing Activities:
Purchase of property and equipment	(20,725)	(23,395)
Software development costs	(686,259)	(586,700)
Net cash flows used in investing activities	(706,984)	(610,095)
Cash Flows from Financing Activities:
Proceeds from issuance of common stock and warrants, net of issuance costs	700,000	4,375,001
Proceeds from exercise of common stock warrants		882,500
Shares repurchased		(3,000)
Proceeds from convertible note payable, net	150,000	126,250
Proceeds from convertible note payable – related parties	126,668
Repayment of convertible note payable		(159,282)
Net cash flows provided by financing activities	976,668	5,221,469
Net change in cash	(2,213,228)	1,834,463
Cash at beginning of year	2,634,794	800,331
Cash at end of year	421,566	2,634,794
Supplemental disclosure of non-cash flow information
Common stock issued to customer for early adoption		$ 20,000